UMMD Pediatric Oncology Takes Over Study Leadership of GPOH-MET Registry
The pediatric oncology department of the University Medical Center Magdeburg with internationally outstanding expertise for children with endocrine cancers.
Magdeburg (UMMD) - The Pediatric Hematology and Oncology Unit of the University Children's Hospital under the direction of Dr. Antje Redlich has taken over the study management of the GPOH-MET Registry (Society for Pediatric Oncology and Hematology - Malignant Endocrine Tumors) for children with thyroid carcinomas, adrenal tumors and neuroendocrine tumors in Magdeburg. After a new call for tenders, the University Medical Center Magdeburg was able to prevail over several national applicants. This competence team consists of a study director, study physicians, a national study committee and study documentalists with oncological experience. In this position, the national expertise for children with malignant endocrine tumors is located at Magdeburg. Prof. Hans-Jochen Heinze, Medical Director of Magdeburg University Hospital, commented: "This is excellent news to consolidate the improvement and further development of comprehensive pediatric oncology care. Likewise, this is an important milestone in our commitment to offer our patients of all ages cutting-edge medicine at the highest medical and scientific level."
Photo: Antje Redlich, MD, and the pediatric oncology team at Magdeburg University Medical Center, in front of the University Children's Hospital. Photographer: Melitta Schubert/UMMD
How the Society for Pediatric Oncology and Hematology works
In the Society for Pediatric Oncology and Hematology (GPOH), physicians, scientists, nurses, psychological and other professionals work together with the goal of providing the best care in the fields of tumor research, tumor prevention, early tumor detection, tumor diagnostics, tumor therapy, and follow-up care for malignant diseases and blood disorders in children and adolescents.
In this context, children with cancer in Germany are cared for in therapy optimization studies or registries in order to bundle expertise and to be able to treat the children in the best possible way. The heads of these studies of the pediatric oncology society are assigned by a vote of the GPOH members (after concept submission and review).
Photo: Antje Redlich, MD. Photographer: Melitta Schubert/ UMMD
Dr. Antje Redlich übernimmt die kinderärztliche Leitung im Endokrinen Referenznetzwerk der Europäischen Union (Endo-ERN)
Dr. Antje Redlich was elected Pediatric Chair for Endocrine Tumor Disposition Syndromes of the European Union Endocrine Reference Network on June 17, 2021.
European Reference Networks (ERNs) are virtual networks that bring together healthcare providers across Europe with the aim of promoting exchange on complex or rare diseases and conditions that require highly specialized care and concentrated knowledge and resources.
This European reference network aims to use its pooled international expertise to provide highly qualified and specialized care to patients with rare and complex diseases across Europe.
"It is important to me to know that this is understood as an achievement of the entire pediatric oncology team in Magdeburg. Clinically and scientifically outstanding pediatric oncology at the Magdeburg site is essential in order to be able to provide the best possible care for children with cancer in northern Saxony-Anhalt in the long term," says Dr. Antje Redlich.